Connection
 
																	
																		
Sarah Johnson to Molecular Targeted Therapy  
																	
																		
																	
																	
																		This is a "connection" page, showing publications Sarah Johnson has written about Molecular Targeted Therapy.  
 
																	
																		
																	
																	
																			
																					
	
						
				
		
			
			
			| 
				
				
			 | 
			
				
				
					|   | 
					Connection Strength  | 
					  | 
				 
				
					  | 
					   | 
					  | 
				 
				
					|   | 
					0.086  | 
					  | 
				 
				 
			 | 
			
				
				
			 | 
			
			
		 
	 	
	
	
		
		
			- 
				Johnson SK, Heuck CJ, Albino AP, Qu P, Zhang Q, Barlogie B, Shaughnessy JD. The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma. Int J Hematol. 2011 Oct; 94(4):321-333.	
				
				
					Score: 0.086